These data strongly suggest that lifetime muscle overexpression of Nrf2 prevents aging-induced cardiac diastolic dysfunction, providing a novel strategy to ameliorate age-associated heart failure with reduced ejection fraction (HFrEF). This evidence concerns the gene NFE2L2 and heart failure.